Search Results - "Pieters, Willem R"

Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients by Augustin, Ingrid M L, Franssen, Frits M E, Houben-Wilke, Sarah, Janssen, Daisy J A, Gaffron, Swetlana, Pennings, Herman-Jan, Smeenk, Frank W J M, Pieters, Willem R, Hoogerwerf, Amber, Michels, Arent-Jan, van Merode, Frits, Wouters, Emiel F M, Spruit, Martijn A

“…Clusters of COPD patients have been reported in order to individualize the treatment program. Neither co-morbidity clusters, nor integrated respiratory…”
Get full text

Quality of routine spirometry tests in Dutch general practices by Schermer, Tjard R J, Crockett, Alan J, Poels, Patrick J P, van Dijke, Jacob J, Akkermans, Reinier P, Vlek, Hans F, Pieters, Willem R

“…Spirometry is an indispensable tool for diagnosis and monitoring of chronic airways disease in primary care. To establish the quality of routine spirometry…”
Get full text

Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma by Pieters, Willem R, Wilson, Koo K, Smith, Heather C E, Tamminga, Johannes J, Sondhi, Seema

“…Asthma, owing to its chronic nature, is associated with a substantial economic burden. Healthcare providers need to compare the cost effectiveness of…”
Get full text

Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies by Pieters, Willem R., Lundb??ck, Bo, Johansson, Gunnar, Palmqvist, Mona, Price, Martin J., Sondhi, Seema, Thwaites, Robert M.A., Yan, Songkai

Get full text

Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients by Ingrid M L Augustin, Frits M E Franssen, Sarah Houben-Wilke, Daisy J A Janssen, Swetlana Gaffron, Herman-Jan Pennings, Frank W J M Smeenk, Willem R Pieters, Amber Hoogerwerf, Arent-Jan Michels, Frits van Merode, Emiel F M Wouters, Martijn A Spruit

“…BackgroundClusters of COPD patients have been reported in order to individualize the treatment program. Neither co-morbidity clusters, nor integrated…”
Get full text

Reduced cost of managing exacerbations with stable dose treatment with salmeterol/fluticasone (SFC) compared with adjustable maintenance dosing (AMD) with formoterol/budesonide (FBC) by Pieters, Willem R., Williams, Angela E., Follows, Richard

Get full text

Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/500 mu g vs fluticasone propionate 500 mu g in patients with corticosteroid-dependent asthma V: Results by Pieters, WR, Lundback, B, Sondhi, S, Price, MJ, Thwaites, RMA

Get full text

Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500??g vs Fluticasone Propionate 500??g in Patients with Corticosteroid-Dependent Asthma V: Results by Pieters, Willem R., Lundb??ck, Bo, Sondhi, Seema, Price, Martin J., Thwaites, Robert M.A.

Get full text

Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview by Lundbäck, Bo, Pieters, Willem R., Johansson, Gunnar, Palmqvist, Mona, Price, Martin J., Sondhi, Seema, Thwaites, Robert M.A.

Get full text